Now, questions about their potential impact on oral health are emerging, with the term Ozempic mouth being used to describe symptoms associated with the use of GLP-1 medications
When we switch them to tirzepatide, the nausea resolves almost entirely
However, the optimal duration of treatment may vary depending on individual factors, such as weight loss goals, health status, and response to the medication
A recent study in JAMA Ophthalmology suggests that patients using Ozempic and Wegovy may face a higher risk of developing non-arteritic anterior ischemic optic neuropathy (NAION), a rare condition causing sudden vision loss
Patients taking this GLP-1 receptor agonist often experience meaningful weight loss
When lifestyle and dietary modifications provide insufficient relief, several medical interventions may help manage GLP-1-related bloating